BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16078278)

  • 1. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor.
    Jin Y; Damaj BB; Maghazachi AA
    Eur J Immunol; 2005 Sep; 35(9):2699-708. PubMed ID: 16078278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro.
    Spangelo BL; Jarvis WD
    Endocrinology; 1996 Oct; 137(10):4419-26. PubMed ID: 8828503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
    Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
    J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE; Fehniger TA; Caligiuri MA
    Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized lipids and lysophosphatidylcholine induce the chemotaxis and intracellular calcium influx in natural killer cells.
    Rolin J; Al-Jaderi Z; Maghazachi AA
    Immunobiology; 2013 Jun; 218(6):875-83. PubMed ID: 23200035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
    Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12.
    Ceballos A; Sabatté J; Nahmod K; Martínez D; Salamone G; Vermeulen M; Maggini J; Salomón H; Geffner J
    Immunology; 2007 Jul; 121(3):328-36. PubMed ID: 17371542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.
    Saito S; Kasahara T; Sakakura S; Enomoto M; Umekage H; Harada N; Morii T; Nishikawa K; Narita N; Ichijo M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):378-83. PubMed ID: 7513162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
    Borrego F; Peña J; Solana R
    Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
    Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis toxin-sensitive GTP-binding proteins regulate activation-induced apoptotic cell death of human natural killer cells.
    Carracedo J; Ramírez R; Marchetti P; Pintado OC; Baixeras E; Martínez C; Kroemer G
    Eur J Immunol; 1995 Nov; 25(11):3094-9. PubMed ID: 7489748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.
    Saito S; Nishikawa K; Morii T; Enomoto M; Narita N; Motoyoshi K; Ichijo M
    Int Immunol; 1993 May; 5(5):559-63. PubMed ID: 7686393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis.
    Lee HY; Shin EH; Bae YS
    Acta Pharmacol Sin; 2006 Oct; 27(10):1359-66. PubMed ID: 17007744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by stem cell factor of interleukin-2 (IL-2)-induced DNA synthesis in human decidual CD16- CD56bright natural killer cells mediated by increased expression of the IL-2 receptor alpha chain.
    Umekage H; Saito S; Morikawa H
    J Reprod Immunol; 1998 Oct; 40(1):1-24. PubMed ID: 9862254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.